Skip navigational links

Life Sciences Newsletter, September 2008


Volume 2, Issue 2
Editor: Seth David Levy, Esq.

  • Generics: Hot Issues as Hatch-Waxman Approaches Its 25th Year
    Karen Gibbs, Esquire

  • Supreme Court Precludes State Tort Damage Claims Against Medical Device Manufacturers
    Stuart Silverman, Esquire

  • False Claims Act Retaliation Claims not Dependent upon Proof of Actual FCA Violation, but Proof Requirements Remain Unclear
    Kerry Parker, Esquire, and Daniel Levy, Esquire

  • Merck Settles Vioxx� Litigation with State Attorneys General: An Analysis
    Arnold Friede, Esquire, Elizabeth Hack, Esquire, Robert Nicholas, Esq., Paul Radensky, Esquire, and T. Reed Stephens, Esquire
© 2018 American Health Lawyers Association. All rights reserved. 1620 Eye Street NW, 6th Floor, Washington, DC 20006-4010 P. 202-833-1100 F. 202-833-1105